Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

QGEN

Qiagen NV

May 14 • 03:08PM ET

45.03

Dollar change +0.70
Percentage change 1.59	%

Healthcare • Diagnostics & Research • Netherlands • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IWR IWD ROBO IWS FXH BBH IWB IYH AIVL VONV

Scroll to Statements

Index	-	P/E	29.99	EPS (ttm)	1.50	Insider Own	0.48%	Shs Outstand	226.45M	Perf Week	4.85%
Market Cap	9.97B	Forward P/E	19.71	EPS next Y	2.28	Insider Trans	0.00%	Shs Float	220.30M	Perf Month	13.52%
Income	336.94M	PEG	18.07	EPS next Q	0.51	Inst Own	57.70%	Short Float	1.32%	Perf Quarter	5.07%
Sales	1.94B	P/S	5.14	EPS this Y	0.57%	Inst Trans	0.60%	Short Ratio	2.89	Perf Half Y	18.37%
Book/sh	16.81	P/B	2.68	EPS next Y	8.70%	ROA	5.58%	Short Interest	2.91M	Perf Year	-0.11%
Cash/sh	4.03	P/C	11.16	EPS next 5Y	1.66%	ROE	9.41%	52W Range	34.74 - 47.69	Perf YTD	3.71%
Dividend Est.	-	P/FCF	32.18	EPS past 5Y	12.66%	ROI	7.47%	52W High	-5.58%	Beta	0.43
Dividend TTM	-	Quick Ratio	1.45	Sales past 5Y	6.29%	Gross Margin	62.23%	52W Low	29.65%	ATR (14)	0.69
Dividend Ex-Date	Jan 30, 2024	Current Ratio	1.84	EPS Y/Y TTM	-19.54%	Oper. Margin	22.75%	RSI (14)	72.33	Volatility	1.09% 1.42%
Employees	5967	Debt/Eq	0.42	Sales Y/Y TTM	-2.99%	Profit Margin	17.38%	Recom	1.91	Target Price	50.46
Option/Short	Yes / Yes	LT Debt/Eq	0.25	EPS Q/Q	-6.34%	Payout	0.00%	Rel Volume	0.54	Prev Close	44.33
Sales Surprise	1.12%	EPS Surprise	4.95%	Sales Q/Q	-5.48%	Earnings	Apr 29 AMC	Avg Volume	1.01M	Price	45.03
SMA20	7.42%	SMA50	5.87%	SMA200	6.71%	Trades		Volume	471,959	Change	1.59%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$44
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Dec-07-23	Upgrade	Goldman	Neutral → Buy	$50
Sep-12-23	Initiated	Robert W. Baird	Outperform	$50
May-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-18-22	Initiated	Morgan Stanley	Equal-Weight
Jan-18-22	Upgrade	DZ Bank	Hold → Buy
Oct-15-21	Resumed	Cowen	Market Perform	$55
Oct-14-21	Initiated	Redburn	Buy
Jul-14-21	Downgrade	Kepler	Buy → Hold	$49.53
Jun-03-21	Initiated	Goldman	Neutral	$52
Oct-06-20	Resumed	BofA Securities	Buy	$59
Sep-28-20	Upgrade	Kepler	Hold → Buy
Aug-24-20	Upgrade	Citigroup	Neutral → Buy	$48 → $62
Aug-20-20	Resumed	JP Morgan	Overweight	$60
Aug-17-20	Upgrade	Berenberg	Hold → Buy
Aug-14-20	Upgrade	Exane BNP Paribas	Neutral → Outperform
Aug-14-20	Upgrade	Deutsche Bank	Hold → Buy
Mar-04-20	Downgrade	Berenberg	Buy → Hold
Jan-08-20	Initiated	Wells Fargo	Equal Weight	$36

Show Previous Ratings

Today 10:08AM	QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus (Zacks)
May-13-24 12:22PM	QIAGEN (QGEN) to Enhance Forensics With New Partnership (Zacks)
07:02AM	Qiagens QIAstat-Dx respiratory diagnostic wins FDA clearance (Medical Device Network)
04:18AM	Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test (MT Newswires)
02:00AM	QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results (GlobeNewswire)
09:03AM	Loading…
May-08-24 09:03AM	Qiagen and FBI partner on DNA quant digital PCR assays (Medical Device Network)
May-07-24 04:05PM	QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics (GlobeNewswire)
May-06-24 08:52AM	International Markets and Qiagen (QGEN): A Deep Dive for Investors (Zacks)
May-02-24 04:05PM	QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications (GlobeNewswire)
May-01-24 12:49PM	Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 12:26PM	QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand (Zacks)
11:37AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Apr-29-24 08:54PM	QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings (Zacks)
05:25PM	Qiagen (QGEN) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:48PM	Loading…
04:48PM	Qiagen Q1 Adjusted Earnings, Sales Decline; Q2 Outlook Issued, 2024 Guidance Affirms -- Shares Fall After Hours (MT Newswires)
04:26PM	Qiagen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance (GlobeNewswire)
Apr-25-24 09:44PM	7 Best Sites Like Ancestry.com to Research Your Family History (Insider Monkey)
Apr-24-24 04:05PM	QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance (GlobeNewswire)
09:15AM	Unveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-09-24 09:48AM	QIAGEN N.V. to release results for Q1 2024 and hold webcast (GlobeNewswire)
Apr-04-24 01:22PM	QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches (Zacks)
Apr-03-24 04:05PM	QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 (GlobeNewswire)
Mar-26-24 10:07AM	QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access (Zacks)
Mar-25-24 04:05PM	QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system (GlobeNewswire)
09:10AM	QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness (Zacks)
Mar-18-24 04:05PM	QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements (GlobeNewswire)
Mar-11-24 05:59AM	QIAGEN announces Form 20-F annual report filing for 2023 results (GlobeNewswire)
Mar-07-24 11:31AM	Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue? (Zacks)
08:39AM	Loading…
Mar-04-24 08:39AM	QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base (Zacks)
Feb-27-24 05:44PM	QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery (GlobeNewswire)
04:05PM	QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification (GlobeNewswire)
Feb-19-24 09:09AM	QIAGEN (QGEN) Earns Notable Recognitions in Sustainability (Zacks)
Feb-15-24 04:05PM	QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification (GlobeNewswire)
Feb-13-24 08:26AM	Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-07-24 11:54AM	Analyst Report: Qiagen N.V. (Morningstar Research)
07:20AM	QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands (Zacks)
Feb-06-24 08:00PM	Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:42PM	Qiagen: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability (GlobeNewswire)
Jan-31-24 07:35AM	QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences (Zacks)
Jan-25-24 10:00AM	QIAGEN announces partnership with Penn State University to advance microbiome sciences (GlobeNewswire)
Jan-18-24 04:05PM	QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million (GlobeNewswire)
Jan-12-24 08:37AM	QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay (Zacks)
Jan-11-24 07:53AM	QIAGEN N.V. to release results for Q4 2023 and hold webcast (GlobeNewswire)
Jan-09-24 10:54AM	QIAGEN (QGEN) Gains From New Alliances Amid FX Headwind (Zacks)
Jan-08-24 02:00AM	QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems (GlobeNewswire)
Jan-07-24 01:07PM	QIAGEN announces plans to return approximately $300 million to shareholders (GlobeNewswire)
Jan-04-24 04:05PM	QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business (GlobeNewswire)
Jan-03-24 02:00AM	QIAGEN expands business in Middle East with new regional headquarters and major projects (GlobeNewswire)
Dec-28-23 07:25AM	Here's Why You Should Retain QIAGEN (QGEN) Stock for Now (Zacks)
Dec-13-23 12:19PM	QIAGEN's (QGEN) Strategic Alliances Aid Amid Macro Woes (Zacks)
Nov-30-23 04:05PM	DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy (GlobeNewswire)
Nov-29-23 11:30AM	Qiagen (QGEN) Up 9.9% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-16-23 09:58AM	QIAGEN (QGEN) Expands Sample Technologies Line With New Launch (Zacks)
Nov-15-23 04:05PM	QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation (GlobeNewswire)
06:32AM	QIAGEN (QGEN) Launches QIAcuity Kits and Software Update (Zacks)
Nov-09-23 04:05PM	QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers (GlobeNewswire)
Nov-07-23 07:01AM	QIAGEN (QGEN) Launches Workflow to Boost Microbiome Research (Zacks)
Nov-06-23 04:05PM	QIAGEN launches complete Sample to Insight workflow for microbiome research (GlobeNewswire)
08:35AM	QIAGEN's (QGEN) Molecular Diagnostics Gains Share, FX Woe Stays (Zacks)
Nov-02-23 08:00AM	QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System (GlobeNewswire)
Nov-01-23 12:26PM	Qiagen N.V. (NYSE:QGEN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-31-23 11:41AM	Analyst Report: Qiagen N.V. (Morningstar Research) +5.29%
07:37AM	QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down (Zacks)
Oct-30-23 07:30PM	Qiagen (QGEN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
06:40PM	Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
05:27PM	Qiagen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CER (GlobeNewswire)
Oct-26-23 08:00AM	QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer (GlobeNewswire)
Oct-24-23 10:00AM	Earnings Preview: Techne (TECH) Q1 Earnings Expected to Decline (Zacks)
Oct-23-23 10:00AM	Earnings Preview: Qiagen (QGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-18-23 10:59AM	Here's Why You Should Retain QIAGEN (QGEN) Stock for Now (Zacks)
Oct-09-23 11:56AM	Analyst Report: Qiagen N.V. (Morningstar Research)
11:14AM	QIAGEN N.V. to release results for Q3 2023 and hold webcast (GlobeNewswire)
Oct-05-23 09:51AM	QIAGEN (QGEN) Broadens QuantiFERON Line With EBV RUO Assay (Zacks)
Oct-04-23 04:05PM	QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus (GlobeNewswire)
Oct-02-23 11:35AM	Charles River (CRL) Launches LVV-based Gene Therapy Platform (Zacks)
09:14AM	QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software (Zacks)
Sep-28-23 04:05PM	QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness (GlobeNewswire)
07:52AM	QIAGENs QuantiFERON solutions recommended for use by kidney specialists in Tunisia (GlobeNewswire)
Sep-27-23 04:05PM	QIAGEN reports progress toward achieving Environmental, Social and Governance goals in 2022 Sustainability Report (GlobeNewswire)
Sep-26-23 08:44AM	QIAGEN (QGEN) Extends QIAwave Product Line With New Kit (Zacks)
Sep-25-23 04:05PM	QIAGEN enhances QIAwave portfolio with new eco-friendlier nucleic acid extraction kits (GlobeNewswire)
Sep-24-23 10:30AM	Bearish Bets: 3 Stocks You Really Should Think About Shorting This Week (TheStreet.com)
Sep-12-23 10:08AM	QIAGEN's (QGEN) New API Streamlines Access to BKB Data (Zacks)
Sep-07-23 11:30AM	Why Is Qiagen (QGEN) Down 4.8% Since Last Earnings Report? (Zacks)
Aug-09-23 10:24AM	Analyst Report: Qiagen N.V. (Morningstar Research)
08:21AM	QIAGEN (QGEN) Q2 Earnings and Revenues Top, '23 View Slashed (Zacks)
Aug-08-23 06:05PM	Qiagen (QGEN) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
05:02PM	Qiagen: Q2 Earnings Snapshot (AP Finance)
04:05PM	QIAGEN delivers ahead of outlook for Q2 2023 with 9% CER sales growth in non-COVID products and updates 2023 full-year outlook (GlobeNewswire)
12:48PM	QIAGEN (QGEN) Receives FDA Approval for AYVAKIT CDX Test (Zacks)
Aug-07-23 04:05PM	QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines AYVAKIT® (avapritinib) in gastrointestinal stromal tumors (GlobeNewswire)
02:03PM	Investors in Qiagen (NYSE:QGEN) have seen returns of 21% over the past five years (Simply Wall St.)
Jul-26-23 04:15PM	Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement (GlobeNewswire)
Jul-24-23 07:41AM	QIAGEN N.V. to release results for Q2 2023 and hold webcast (GlobeNewswire)
Jul-20-23 09:16AM	QIAGEN (QGEN) Expands Digital PCR Offering With New Pact (Zacks)
Jul-19-23 10:01AM	Alkermes (ALKS) Earnings Expected to Grow: Should You Buy? (Zacks)

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QGEN

Qiagen NV

Upgrade your FINVIZ experience